medicrea
-
Spine
Medicrea Acquires 3 Patents from Dr. Paul McAfee to Enhance Surgical Planning of 3D-Printed Titanium Interbody Devices
November 28, 2017 NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence of healthcare IT…
Read More » -
Hospitals
Medicrea Receives FDA Clearance for 3D-Printed Titanium Interbody Devices and Introduces AdapTEK™ Surgeon-Adaptive Technology
November 22, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea® Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence of…
Read More » -
Spine
Medicrea Unveils New U.S. Business Development Model with Hiring of Joseph Walland as Executive Vice President of Sales and Richard Washburn as Executive Vice President UNiD™ ASI
October 25, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence…
Read More » -
Financial
Medicrea Reports Third Quarter 2017 Sales
October 12, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence…
Read More » -
Spine
Medicrea Presents Patient-Specific UNiD™ Rod Clinical Results Showing Very Significant Reduction in Rod Breakage
October 02, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence…
Read More » -
Financial
Medicrea Financial Calendar Amendment
September 27, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence…
Read More » -
Spine
Medicrea Partners with Orthopaedic Surgeon in World’s First 360-Degree Personalized Spine Surgery
September 26, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence…
Read More » -
Spine
Medicrea Announces World’s First Minimally-Invasive Spine Surgery Using Patient-Specific Implants
July 31, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence…
Read More » -
Financial
Medicrea Reports First Half 2017 Sales
July 11, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence…
Read More » -
Financial
Medicrea Announces Capital Raise of € 13 Million Through a Successful Private Placement
June 19, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (ISIN : FR0004178572 – ALMED, eligible to PEA-PME), pioneering the…
Read More » -
Hospitals
Medicrea Announces FDA Clearance and Initial Experience with PASS® TULIP Top-Loading Fixation
June 16, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Alternext Paris: FR0004178572 – ALMED), pioneering the convergence of…
Read More » -
Hospitals
Medicrea Receives FDA Clearance for the UNiD™ HUB, a Data-Driven Digital Portal for Adaptive Spine Intelligence
June 16, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Alternext Paris: FR0004178572 – ALMED), pioneering the convergence of…
Read More » -
Financial
Medicrea Releases First Quarter Sales For 2017
April 13, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Alternext Paris: FR0004178572 – ALMED), worldwide leader pioneering the…
Read More » -
Financial
Medicrea Releases Annual Sales for 2016
January 12, 2017 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA Group (Alternext Paris: FR0004178572 – ALMED), worldwide leader pioneering the…
Read More » -
Hospitals
Medicrea Announces 510(k) Submission for FDA Clearance of Proprietary 3D-Printed Titanium Spinal Interbody Devices
January 09, 2017 01:30 AM Eastern Standard Time LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Alternext Paris: FR0004178572 –…
Read More »